Two studies – one with humans and the other with laboratory animals – suggest that coenzymeQ10 supplementation may benefit patients with Parkinson’s, a common neurodegenerative disorder without a cure that affects about 1-2 percent of the population above the age of 55.
Parkinson’s is a movement disease, the result of brain cells not producing enough of an important chemical called dopamine. Symptoms, which become progressive, include trembling of the hands, arms, legs, jaw, and face; stiffness; slowness of movement; and poor balance and coordination. CoQ10, an antioxidant compound made in the body, is an essential element for cellular energy production. As the body ages, it makes less.
The human study involved sixteen subjects with early Parkinson’s. They were given progressively higher doses of a CoQ10 supplement over an eight-week period. The researchers found that doses from 400 to 1200 milligrams yielded a significant reduction in a particular oxidative compound – called F2 isoprostane – associated with a number of common diseases. Improvements in symptoms were reported among subjects who had lower CoQ10 levels to begin with.
In the animal study, Parkinson’s disease was induced in rodents who were then treated with CoQ10. The researchers found that continual supplementation of the rodent’s drinking water resulted in a significant reduction of brain neuronal damage and slowdown of the disease progression.
Learn More…
© 2014 HeartMD Institute. All rights reserved.